Tissue Regenix Group plc

Company Profile

Company website
Pharmaceuticals & Biotechnology (Biotechnology)
Tissue Regenix Group plc (AIM: TRX) is a pioneering, international medical technology company focused on the development of regenerative products using two platform technologies, dCELL®, addressing soft tissue needs, and BioRinse™, providing inductive bone allografts.

Investor Access

Event information

There is no Investor Access event planned at the moment - click on "Register your Interest" and we'll tell the Company that you'd like to attend one in the future and update you when an event is planned.

Financial Calendar
 Event  Date
Year End 31 December
Half  Year End 30 June
Preliminary Results* June
Interim Results* September
AGM* June

* Months based on previous announcements of this kind